Marshall Wace
SLGC

Marshall Wace’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Marshall Wace’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-144,183
Closed -$365K – 2929
2023
Q4 		$365K Sell
144,183
-1,937,615
-93% -$4.51M ﹤0.01% 1831
2023
Q3 		$4.98M Sell
2,081,798
-477,910
-19% -$1.06M 0.01% 868
2023
Q2 		$5.91M Hold
2,559,708
– – 0.01% 945
2023
Q1 		$6.53M Hold
2,559,708
– – 0.01% 869
2022
Q4 		$6.42M Sell
2,559,708
-436,818
-15% -$1.22M 0.01% 1034
2022
Q3 		$8.69M Buy
2,996,526
+609,278
+26% +$2.56M 0.02% 981
2022
Q2 		$10.8M Sell
2,387,248
-461,304
-16% -$2.74M 0.02% 818
2022
Q1 		$22.8M Buy
2,848,552
+391,944
+16% +$3.46M 0.04% 447
2021
Q4 		$28.6M Buy
2,456,608
+793,740
+48% +$9.51M 0.05% 367
2021
Q3 		$20.6M Buy
+1,662,868
New +$18.8M 0.09% 261

Marshall Wace's SLGC Position: Q1 2024 in Review

Marshall Wace sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 144,183 shares — an estimated $365K sold.

Marshall Wace first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $28.6M in Q4 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Marshall Wace reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Marshall Wace sold 144,183 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $365K.
  • Marshall Wace first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Marshall Wace's SomaLogic, Inc. Class A Common Stock position peaked at $28.6M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.